{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:17:44Z","timestamp":1761898664566,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.clinre.2020.07.022","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T08:23:50Z","timestamp":1599380630000},"page":"101517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["De novo hepatocellular carcinoma in cirrhotic hepatitis C virus: Are directly acting antivirals beneficial?"],"prefix":"10.1016","volume":"45","author":[{"given":"Iman F.","family":"Montasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda M.","family":"Farid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira M.","family":"Al Balakosy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2020.07.022_bib0135","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.21176","article-title":"The natural history of compensated cirrhosis due to hepatitis C virus. A 17-year cohort study of 214 patients","volume":"43","author":"Sangiovanni","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2020.07.022_bib0140","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clinre.2020.07.022_bib0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/liv.13186","article-title":"The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment","volume":"37","author":"Kandeel","year":"2017","journal-title":"Liver Int J"},{"key":"10.1016\/j.clinre.2020.07.022_bib0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma. A meta-analysis of observational study","volume":"158","author":"Morgan","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2020.07.022_bib0155","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","article-title":"Hepatitis C virus infection","volume":"3","author":"Manns","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clinre.2020.07.022_bib0160","first-page":"47","article-title":"Chronic hepatitis C virus infection. A review of current direct-acting antiviral treatment strategies","volume":"9","author":"Zhang","year":"2016","journal-title":"N Am J Med Sci"},{"key":"10.1016\/j.clinre.2020.07.022_bib0165","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jhep.2016.06.019","article-title":"Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis","volume":"65","author":"Cheung","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2020.07.022_bib0170","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jhep.2016.01.029","article-title":"Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis","volume":"64","author":"Foster","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2020.07.022_bib0175","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","article-title":"Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals","volume":"65","author":"Conti","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2020.07.022_bib0180","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2020.07.022_bib0185","doi-asserted-by":"crossref","first-page":"e0179096","DOI":"10.1371\/journal.pone.0179096","article-title":"on treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C","volume":"12","author":"Chu","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.clinre.2020.07.022_bib0190","doi-asserted-by":"crossref","first-page":"e0167934","DOI":"10.1371\/journal.pone.0167934","article-title":"DAAs rapidly reduce inflammation but increase serum VEGF level: a rationale for tumor risk during anti-HCV treatment","volume":"11","author":"Villani","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2020.07.022_bib0195","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2020.07.022_bib0200","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma. Practice guidance by the American Association for the study of liver diseases","volume":"68","author":"MarreroJA","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2020.07.022_bib0205","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2020.07.022_bib0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection, comparison with liver biopsy and fibro test","volume":"46","author":"Pichard","year":"2007","journal-title":"Hepatol J"},{"issue":"2","key":"10.1016\/j.clinre.2020.07.022_bib0215","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00595-013-0585-6","article-title":"Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus","volume":"44","author":"Katagiri","year":"2014","journal-title":"Surg Today"},{"key":"10.1016\/j.clinre.2020.07.022_bib0220","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"year":"2011","series-title":"Egyptian guidelines for management of hepatocellular carcinoma","author":"Egyptian Society of Liver Cancer","key":"10.1016\/j.clinre.2020.07.022_bib0225"},{"key":"10.1016\/j.clinre.2020.07.022_bib0230","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.cgh.2018.10.038","article-title":"Factors associated with increased risk of de novo or recurrent hepatocellular carcinoma in patients with cirrhosis treated with direct-acting antivirals for HCV infection","volume":"17","author":"Degasperi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2020.07.022_bib0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhep.2018.03.009","article-title":"Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs. A prospective population study","volume":"69","author":"Romano","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2020.07.022_bib0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MEG.0000000000001264","article-title":"Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals. Comparative analysis with non-direct-acting antivirals-treated patients","volume":"31","author":"Abdelaziz","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2020.07.022_bib0245","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jhep.2011.10.021","article-title":"Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines","volume":"56","author":"Takayasu","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2020.07.022_bib0250","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy","volume":"65","author":"Reig","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2020.07.022_bib0255","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s00330-017-5033-3","article-title":"Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis","volume":"28","author":"Renzulli","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clinre.2020.07.022_bib0260","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jvh.12854","article-title":"Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort. A comparative analysis","volume":"25","author":"El Kassas","year":"2018","journal-title":"J Viral Hepat"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740120302126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740120302126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:41Z","timestamp":1761895901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740120302126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2210740120302126"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2020.07.022","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De novo hepatocellular carcinoma in cirrhotic hepatitis C virus: Are directly acting antivirals beneficial?","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2020.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101517"}}